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Mini-Symposium

The Epigenetics of Sex Differences in the Brain
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Elaine K. Murray,4 Bridget M. Nugent,1 Jaclyn M. Schwarz,5 and Melinda E. Wilson6
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Department of Physiology and Program in Neuroscience, University of Maryland School of Medicine, Baltimore, Maryland 21201-1559, 2Department of
Psychology, University of Wisconsin, Madison, Wisconsin 53706-1611, 3Department of Animal Biology, University of Pennsylvania, Philadelphia,
Pennsylvania 19104-6009, 4Department of Psychology and Center for Neuroendocrine Studies, University of Massachusetts, Amherst, Massachusetts 01003,
5Department of Psychology and Neuroscience, Duke University, Durham, North Carolina 27708, and 6Department of Physiology, University of Kentucky
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Epigenetic changes in the nervous system are emerging as a critical component of enduring effects induced by early life experience,
hormonal exposure, trauma and injury, or learning and memory. Sex differences in the brain are largely determined by steroid hormone
exposure during a perinatal sensitive period that alters subsequent hormonal and nonhormonal responses throughout the lifespan.
Steroid receptors are members of a nuclear receptor transcription factor superfamily and recruit multiple proteins that possess enzymatic activity relevant to epigenetic changes such as acetylation and methylation. Thus steroid hormones are uniquely poised to exert
epigenetic effects on the developing nervous system to dictate adult sex differences in brain and behavior. Sex differences in the methylation pattern in the promoter of estrogen and progesterone receptor genes are evident in newborns and persist in adults but with a
different pattern. Changes in response to injury and in methyl-binding proteins and steroid receptor coregulatory proteins are also
reported. Many steroid-induced epigenetic changes are opportunistic and restricted to a single lifespan, but new evidence suggests
endocrine-disrupting compounds can exert multigenerational effects. Similarly, maternal diet also induces transgenerational effects, but
the impact is sex specific. The study of epigenetics of sex differences is in its earliest stages, with needed advances in understanding of the
hormonal regulation of enzymes controlling acetylation and methylation, coregulatory proteins, transient versus stable DNA methylation patterns, and sex differences across the epigenome to fully understand sex differences in brain and behavior.

The term “epigenetics” is defined literally as “in addition to genetics” but in reality refers to changes in the DNA or surrounding
chromatin that influence gene expression but do not change genetic composition. There are two identified ways in which meaningful epigenetic changes can occur: (1) the addition of a methyl
group to a cytosine that sits just upstream of a guanine, and is
referred to as a CpG island, and (2) changes to the histones that
form the core of nucleosomes around which DNA is tightly
packed. The dominant changes to histones are methylation and
acetylation of the protruding tails, but can also include ubiquitylation, phosphorylation, and sumoylation (for review, see Goldberg
et al., 2007). All these processes are enzymatically driven and
therefore regulated and reversible. The methylation of DNA is
tightly controlled by a family of DNA methyl transferases
(DNMTs), with DNMT3A and DNMT3B inducing de novo
methylation while DNMT1 predominantly maintains ongoing
methylation. Changes to both the DNA and histones impact gene
transcription but do so in different manners. Direct methylation
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of the DNA at CpG sites profoundly impacts the expression of a
gene but the effect depends on the location. The promoter and
upstream noncoding regions of genes are the principle regulatory
sites of interest, but the sites are not predictable and vary for each
gene. DNA methylation is generally repressive of gene expression,
but exceptions are beginning to emerge. Conversely, changes to
histones occur on specific residues but act globally to relax or
tighten the chromatin surrounding a particular gene and thereby
regulate access of the transcription complex. Two classes of
enzymes have been the focus of investigation, the histone
deacetylases (HDACs), which remove acetyl groups from lysine
residues and thereby tighten the chromatin structure and reduce
transcription, versus histone acetylases (HATs), which perform the
opposite function, adding acetyl groups to lysine residues and
weakening the electric charge between histones and DNA and
relaxing the tightly wound chromatin. There is a relationship
between histone and DNA modifications, with one often preceding and allowing the other and thereby further strengthening the
silencing or activation of a particular gene.
The origins of epigenetics begin in early development with the
single-celled zygote. The paternal genome is actively demethylated before the first cell division, followed shortly thereafter by
demethylation of the maternal genome once the zygote has undergone several cleavage divisions. Proper development requires
de novo methylation of the inner cell mass at the blastocyst stage
and cell differentiation is dependent on maintenance of DNA
methylation of large numbers of genes. Disruption of these events
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by genetic ablation of the DNMTs is generally embryonic lethal
(Li, 2002). Moreover, a loss of maintenance DNA methylation is
a frequent precipitating event in cancer as cellular signals for
proliferation are released from chronic suppression (for review,
see Ellis et al., 2009).
In mammals the role of epigenetics in sex differences also
begins early in development with the critical process of X inactivation in females. To achieve dosage compensation, one of the
two X chromosomes is largely silenced by a combination of histone modifications and DNA methylation (Avner and Heard,
2001). But not all X genes are silenced, and those that are expressed provide a potential source of sex differences in both somatic and neural cells (Chen et al., 2009). Imprinting of paternal
or maternal genes is an additional source of epigenetic control of
sex differences. Genetic imprinting is the systematic suppression of
a portion of a chromosome from one parent via maintenance
DNA methylation, leading to monoallelic expression. Many imprinted genes are associated with body growth, and this has been
interpreted as indicative of the battle between the sexes, with
males wanting to produce as many and as large of offspring as
possible at the expense of the maternal female (Davies et al.,
2008). Others see a logical inconsistency in this argument and
suggest instead that imprinting serves as a coadaptation between
the mother and her offspring and involves a complex interplay of
imprinted gene expression in the placenta, maternal hypothalamus, and fetal brain to regulate nutrient distribution, maternal
care and feeding, and the sexual behavior of adult male progeny
(Keverne and Curley, 2008). Elucidating how X chromosome inactivation and/or genomic imprinting contribute to sex differences
in the brain remains a poorly understood and relatively unexplored
research area.
Epigenetic changes can be further divided into those that
occur in the germline and are therefore heritable, versus those
in somatic cells which generally persist only for the duration of
a lifetime and are largely context dependent (Crews, 2008).
The context may be variables in the internal or external environment, such as steroid hormones or endocrine-disrupting
chemicals, respectively (Gore, 2008). Alternatively the context
may be experiences as profound as early child abuse (McGowan
et al., 2009), or events as mild as context-dependent learning
(Lubin et al., 2008).
Similar to context-dependent epigenetic changes, sex differences in the brain are not an inherent emergent property but are
instead largely determined by extrinsic factors. Chromosomal sex
directs the differentiation of the bipotential gonad, and it is the
steroid hormone production by the gonad that then determines
the phenotype of the brain in regards to relative masculinization
or feminization. Progress is being made on the cellular mechanisms of androgen- and estrogen-induced sexual differentiation
of the brain and spinal cord during a perinatal sensitive window
(for review, see McCarthy et al., 2009), and attention is now
turning toward how epigenetics might contribute to both the
establishment of, and perhaps more importantly, maintenance of
sex differences in the brain. Steroids such as testosterone and
estradiol are ligands for a family of nuclear transcription factors
that recruit numerous coactivators and repressors into a macromolecular complex that includes HATs and HDACs. Thus it is
not surprising that steroids can induce enduring epigenetic
changes in the brain, a notion first elucidated almost 20 years ago
by Pfaff et al. (1992) invoking “gene memory” as an explanation
for the differential sensitivity of male and female brains to estradiolinduced transcription of preproenkephalin in the mediobasal hypothalamus. More recently reported are sex differences in histone
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acetylation in broad brain regions (Tsai et al., 2009). Many of the
participants in this Society for Neuroscience mini-symposium
and coauthors on this report have also been making major inroads into the epigenetic underpinnings of sex differences in the
brain. But it is equally clear we are only at the beginning, and it is
the goal of this mini-review to highlight both what we know so far
and point the spotlight forward to what we do not know but
should.
Steroids impact DNA CpG methylation patterns
The aromatization hypothesis elucidates the principle that androgens produced by the testis lead to masculinization of the
rodent brain in large part only after aromatization to estrogens,
predominantly estradiol (Naftolin et al., 1975). Thus, much of
our current information centers around estradiol and its receptors. There are two main isoforms of the estrogen receptor, ER␣
and ER␤. The dominant receptor developmentally is ER␣, although ER␤ is not unimportant (Kudwa et al., 2005). Overall, the
molecular factors that control ER mRNA expression at the transcriptional level are not well known. One transcription factor,
Stat5, has been shown to regulate ER␣ in the hypothalamus
(Champagne et al., 2006). While the possibility of this factor
regulating ER␣ mRNA in a similar manner in the cortex during
development or after injury cannot be ruled out, it is likely that
additional mechanisms of ER␣ mRNA regulation are involved.
The regulation of gene expression by epigenetic modification is
emerging as an important mechanism for controlling neuronal
gene expression particularly during development. The ER␣ gene
undergoes alterations in promoter methylation during normal as
well as in pathological conditions. For example, methylation of
the ER promoter has been reported to occur in the colon during
aging (Issa et al., 1994), and changes in the expression of ER have
been associated with the progression of breast and lung cancers
(Ottaviano et al., 1994; Sasaki et al., 2002). During a neonatal
sensitive period of brain development, estradiol acts upon ER␣ to
transiently alter gene expression; however, the effects of this exposure persist throughout the individual’s lifespan. One possible
mechanism for a lasting difference in the brain is via an epigenetic
process that creates methyl marks on DNA. Epigenetic processes
begin with methylation of DNA by DNA methyltransferases.
While methylation alone can interfere with protein binding and
gene transcription, it is the binding of methyl-CpG-binding proteins, which subsequently recruit nuclear corepressor and histone
deacetylase repressor complexes, that ultimately represses gene
expression. Emerging evidence suggests sex differences in at least
four related parameters: (1) DNA methylation patterns, (2) methyl
transferases, (3) methyl-binding proteins, and (4) corepressor proteins, all of which can contribute to lasting differences in the brain
(Fig. 1).
Brain sex differences and DNA methylation patterns
Previous research has indicated that the early social/maternal environment can modify sex differences in behavior, and recent
evidence suggests that it may do so in an epigenetic manner.
Variations in maternal care during the early neonatal period has
enduring effects on adult sexual behavior (Moore, 1992; Rhees et
al., 2001; Cameron et al., 2008) and on ER␣ expression by altering
ER␣ promoter methylation (Champagne et al., 2006). As rat
mothers typically groom the anogenital region of males more
than females, it is possible that variations in maternal care may be
contributing to sex differences in behavior by epigenetically
modifying the genome. This would suggest that the mom’s behavior may place marks on DNA that later code for male versus
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grooming may partly establish this sex difference. These data suggest that early social interaction, similar to hormones, may
converge at the genome to organize typical sex differences in the brain via epigenomic differentiation. These data also
suggest how early neonatal experiences
may be stored on DNA and ultimately
shape lasting sex differences in brain and
behavior.
The work of Jaclyn Schwarz and
Bridget Nugent suggests that there may be
a more complex pattern of early epigenetic marks in the developing and adult
POA. In contrast to Auger’s findings,
Schwarz and Nugent saw increased methylation in 1- to 2-d-old pups in the female
POA, when compared to males and
estradiol-treated females, at two specific
CpG sites on the ER␣ promoter. Analysis
at PN60 determined that the percentage of
methylation at many CpG sites along the
ER␣ promoter of adults was nearly double
that of the levels seen at PN1, suggesting a
developmental regulation of ER␣ methylation regardless of sex. The effect of sex
and neonatal hormone exposure at PN1
persisted into adulthood, however, at only
one site along the ER␣ promoter. The individual CpG sites exhibiting changes
during development and in adulthood
were not the same, revealing yet another
level of complexity. As adults, females
have nearly 30% greater methylation at a
CpG site at which there was no effect of
sex or hormone in the neonate. How and
why the pattern of CpG methylation of the
ER␣ promoter changes across developFigure 1. Epigenetics of sex differences in the brain. Emerging evidence suggests sex differences in at least four related ment is not known, but these data indicate
parameters: (1) DNA methylation patterns, (2) methyl transferases, (3) methyl-binding proteins, and (4) corepressor proteins, all that during the critical period of sexual
differentiation, estradiol exposure can
of which can contribute to lasting differences in the brain and behavior.
epigenetically modulate the expression of
its own receptor, ER␣. In contrast, there
female gene transcription rates. The level of ER␣ expression in
was no effect of sex or hormone on the methylation levels dethe preoptic area is sexually dimorphic, with males exhibiting
tected on the ER␤ promoter. The POA is a brain region important to the expression of male sex behavior, and therefore
lower levels during development (DonCarlos and Handa, 1994;
methylation on the ER␣ promoter may be increased in adult
Yokosuka et al., 1997; Yamamoto et al., 2006), and this difference
females in order to silence estradiol-responsive sites relevant to
appears to persist into adulthood (Brown et al., 1988; Lauber et
male sex behavior.
al., 1991; Maerkel et al., 2007). As the ER␣ promoter region is
subject to epigenetic modification by maternal–pup interactions,
The hypothalamus also exhibits sex differences in neuronal
Anthony Auger and colleagues examined whether sex differences
morphology and is a brain region critical to the expression of
occur in ER␣ promoter CpG methylation within the developing
female sexual behavior, making it an important site of estradiolpreoptic area (POA). They also examined whether estradiol or
induced defeminization in the male brain. A concurrent analysis
somatosensory stimuli associated with maternal grooming conto that done in the POA reveals that again 1-d-old females have
tribute to this difference. This would suggest that sex differences
significantly higher levels of methylation than males at two CpG
organized by a transient hormone surge or early social experience
sites along the ER␣ promoter. In contrast to the POA, treatment
of females with estradiol 24 h before analysis only decreased
may be maintained through epigenetic modification of DNA.
methylation at these sites to intermediate levels, not significantly
There is a sex difference in methylation of the ER␣ promoter
within the developing rat preoptic area. Specifically, males exdifferent from either males or females. Analysis of the progesterhibit more ER␣ promoter methylation than females, and the inone receptor (PR) promoter region revealed a similar effect. Fecrease in methylation correlates with the decreased ER␣
males had significantly greater levels of methylation than males at
expression in males, thereby providing evidence that estradiol
one site along the PR promoter, and treatment of females with
exposure and somatosensory stimuli associated with maternal
estradiol intermediately reduced methylation at this same site to
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levels not significantly different from males or females. The induction of PR by estradiol treatment is a well established primary
effect of the steroid. These results expand the epigenetic impact of
estradiol beyond its own receptor to include, at least, progesterone receptor. On the PR promoter, the sex difference seen neonatally was again reversed in adulthood. Specifically, males had a
significantly greater level of methylation than females at the same
CpG site modulated in the neonate. In addition, neonatal treatment of females with estradiol significantly increased methylation at this same CpG site to levels seen in males at adulthood.
Thus this specific CpG site on the PR promoter may be an important site of epigenetic modification by estradiol during development and adulthood.
The POA and hypothalamus are canonical brain regions rich
in ER and subjected to the organizational/activational hypothesis
of steroid-induced sexual differentiation. Both areas exhibit profound and robust sex differences in neuronal and glial morphology and/or number and both areas are critical to the expression of
sexual behavior in adulthood. However ER of both isoforms are
also found in regions outside of the POA and hypothalamus and
with distinct patterns of expression in different brain regions and
with varying levels of expression during different stages of development (DonCarlos, 1996; Shughrue et al., 1997). High levels of
estrogen receptor protein expression in extrahypothalamic areas
including the cortex and hippocampus are observed at birth, but
decline as animals approach puberty (Pfaff and Keiner, 1973). ER
mRNA expression changes correlate with the changes in protein
expression in the hippocampus and cortex (Prewitt and Wilson,
2007), suggesting the developmental changes are in transcriptional regulation and not due to posttranscription or translational processes. To determine whether methylation correlates
with the decline in ER mRNA expression in the cortex during
early postnatal development, Wilson and colleagues examined
the methylation status of several of the ER promoters and found
at least one of the six promoters of the mouse ER␣ gene becomes
progressively methylated beginning at postnatal day 10 in both
male and female mice, which corresponds with the age at which
the decline in ER mRNA expression in the cortex begins.
In addition to the changes in expression in ER␣ mRNA observed during development, ER␣ expression is also dramatically
regulated following brain injury. Low, physiological levels of estradiol prevent cell death in the cortex following middle cerebral
artery occlusion (MCAO) and in this model, the estradiolmediated neuroprotection requires ER␣ (Dubal et al., 2001). As
discussed above, ER␣ expression is very low in the adult cortex,
however, following unilateral MCAO, ER␣ levels in the cortex are
rapidly increased on the injured side of the brain (Dubal et al.,
2006). This upregulation is independent of exogenous estradiol
treatment. Furthermore, the increase in ER␣ mRNA expression
only occurs in females, as males do not show a similar increase in
the absence or presence of estradiol (Westberry et al., 2008).
When Wilson et al. examined the methylation status of the ER
promoter in male and female rats following MCAO they observed that ischemia decreased methylation of the ER␣ promoter
in the ischemic cortex in females, while there was no change in
methylation in the ER␣ promoter in males. Again this difference
was independent of exogenous estradiol treatment, suggesting an
intrinsic gender difference in ER␣ promoter methylation and
mRNA expression.
The data obtained from both the POA and the hypothalamus
indicate that estradiol epigenetically regulates genes underlying
sex differences in the brain and behavior, whereas the data from
the cortex suggest intrinsic factors, i.e., genetic sex, can also me-
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diate epigenetic changes in ER␣. Moreover there are both siteand region-specific developmental changes in the methylation
pattern in the ER␣ promoter, and there is plasticity in response in
the adult as demonstrated by changes following injury. Thus the
estrogen receptor seems to represent a particularly complex yet
facile target for epigenetic regulation. This conclusion is both
expected and surprising. Estrogens and estrogen receptors are
proving to be far more mechanistically multifaceted than ever
imagined, with rapid actions at the membrane as well as the nucleus, local intraneuronal synthesis, and the capacity to activate
kinases and directly modulate ion channel function and hence
neuronal excitability. We can now add epigenetic regulation of
the promoter to the growing list of ways in which this receptor
both modulates and is modulated. Connecting these epigenetic
changes to estrogen-mediated functional endpoints is the more
daunting challenge. While there are many effects of ER that are
directly relevant to neuronal function, there are many more
where ER serves the purpose of regulating a downstream mediator that subsequently alters neuronal morphology or function
(McCarthy, 2008). Thus it could be argued that the important
epigenetic changes are ones induced by ER activation on other
genes, not the ER itself. To date, other than PR, there have been
no such effects identified.
Brain sex differences and methyl-binding proteins
Differences in methylation are only one step in gene repression.
Methylated DNA is then bound by methyl-binding proteins, one
of which is called methyl-CpG-binding protein 2 (MeCP2). Upon
binding to methylated DNA, methyl-binding proteins, such as
MeCP2, recruit corepressor proteins and HDACs to modify chromatin and repress gene transcription (Nan et al., 1998). Interestingly, mutations of the MECP2 gene appear to cause Rett
syndrome (Amir et al., 1999), while subtle reductions of MeCP2
expression are speculated to be associated with male dominated
social and neurodevelopmental disorders (Nagarajan et al.,
2006). To determine whether MeCP2 expression is critical for
social development and sexual differentiation of behavior, we
used siRNA to target local and transient reduction of MeCP2
protein in the developing amygdala. We then assessed the impact
of this reduction on juvenile social play behavior, a behavior
which occurs at higher rates in juvenile males contrasted to females (Olioff and Stewart, 1978). Interestingly, neonatal treatment with MeCP2 siRNA disrupted juvenile social play behavior
in males but not females. In contrast, reduced Mecp2 expression
did not appear to alter juvenile sociability or adult anxiety-like
behavior, suggesting that this disruption may be associated with
subtle behavioral modification (Kurian et al., 2008). These data
support that epigenetic processes, such as methyl-binding proteins, likely contribute to differentiation of brain and social behavior. They also suggest that molecules reading DNA marks are
also important factors for typical social development.
Brain sex differences and corepressors
The next step to gene repression following binding of methylbinding proteins to methylated DNA is the recruitment of corepressor complexes. Corepressors decrease gene transcription
through their association with HDACs (Tsai and O’Malley,
1994). One of the first corepressors to be identified was nuclear
receptor corepressor (NCoR), via its interaction with thyroid
hormone receptors (Hörlein et al., 1995). It was then found to be
a corepressor molecule for androgen and estrogen receptors
(Lavinsky et al., 1998; Yoon and Wong, 2006). NCoR also represses gene expression via its direct or indirect interactions with
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methyl-binding proteins, such as Kaiso (Yoon et al., 2003) and
possibly MeCP2 (Kokura et al., 2001; Cukier et al., 2008). Auger
and colleagues have identified a sex difference in the expression of
NCoR within the developing amygdala, and that estradiol exposure may be partly responsible for this sex difference. The corepressor molecule, NCoR, acts in the brain to blunt sex differences
in juvenile social play behavior in males, and appears critical for
appropriate anxiety-like behavior in both juvenile males and females. As NCoR participates in DNA methylation-induced gene repression, it is possible that abnormal functioning of NCoR may
underlie increased anxiety in some individuals with epigenetic neural developmental disorders associated with NCoR dysfunction,
such as Rett syndrome or Huntington’s disease. As nuclear receptors
are involved in numerous processes within an organism, it is crucial
to understand how these processes govern nuclear receptor activity.
The modification of DNA, methyl-binding proteins, and coregulatory proteins are likely a mechanism for how relatively few molecules
can impact a large number of transcriptional responses or provide a
mechanism for how DNA is transcribed in response to changes in
steroid hormones or the social environment.
Brain sex differences and DNMT activity
The observation of sex differences in CpG methylation within
24 h of birth or after exogenous estradiol treatment prompted
an investigation by Schwarz and colleagues into activity of the
DNMT enzymes which transfer methyl groups to cytosines in
CpG dinucleotides. Overall DNMT activity in the POA of 1-d-old
pups was significantly greater in males than in females, and increased in females by exogenous estradiol treatment consistent
with the direction of effects observed on CpG methylation. Protein levels of DNMT1 and DNMT3, the two isoforms important
for maintenance and de novo methylation respectively, were not
affected by sex or estradiol treatment, suggesting the primary
mode of regulation is activity, not enzyme synthesis. The gratifyingly consistent relationship between DNMT activity and levels
of methylation of ER␣ promoter in the POA was not maintained
for the mediobasal hypothalamus were 1-d-old males also had
significantly higher levels of DNMT activity than females, and
treatment of females with estradiol significantly increased the
activity of DNMTs within 24 h. These results are contrary to
the methylation levels observed on the two genes described
above, ER␣ and PR, and indicate that there may be an estradiolmediated increase in methylation levels of other genes in the
MBH that have not yet been explored. Indeed, this is more in line
of what would be expected, as discussed above, given that estradiol predominantly acts to induce other signal transduction systems to alter neuronal function. Nonetheless, establishing how
estradiol increases DNMT activity will be an important future
direction. Connecting steroid-induced changes in DNMT activity to specific genes will also greatly advance our understanding of
the enduring consequences of hormone exposure during sensitive developmental periods.
Brain sex differences and histone modifications
Morphological sex differences in the nervous system are established by exposure to testosterone and its aromatized endproduct, estradiol, during critical periods in development. In
most cases the mechanism(s) through which testosterone and
estradiol direct these neural changes are not known. Effects of
early exposure to steroids last a lifetime, and there is often a delay
between the hormone exposure and the appearance of a morphological sex difference. For example, the bed nucleus of the stria
terminalis (BNST) is a limbic forebrain region that exhibits sev-
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eral sex differences. The most prominent region of the BNST, the
principal nucleus (BNSTp), is larger in volume and contains
more cells in males than in females. This has been established in
mice, rats, guinea pigs, and humans (Hines et al., 1985, 1992;
Guillamón et al., 1988; Forger et al., 2004). In mice and rats, this
sex difference is due to greater developmental cell death in females. The sex difference in cell death is not apparent until approximately postnatal day 6, but is determined by testosterone
exposure on the day of birth (Chung et al., 2000; Gotsiridze et al.,
2007; Hisasue et al., 2007).
Elaine Murray and colleagues hypothesized that sexual differentiation of BNSTp cell number requires orchestrated changes in
histone acetylation following testosterone exposure. As discussed
above, several of the best-known steroid hormone receptor coactivators have HAT activity or recruit HATs to the transcription
complex whereas corepressors often have HDAC activity (Spencer et
al., 1997; Kishimoto et al., 2006; Kininis et al., 2007). To test
whether sex differences in the BNSTp require changes in histone
acetylation/deacetylation, Murray and colleagues administered
an HDAC inhibitor, valproic acid (VPA), to neonatal mice during the critical period for sexual differentiation. They found that
treatment with the HDAC inhibitor transiently increased histone
H3 acetylation level in the brain of newborn mice (Murray et al.,
2009a). In addition, when examined at 3 weeks of age (i.e., after
the period of sexual differentiation), males and androgenized
females treated with VPA had female-like volume and cell number in the BNSTp. Thus, inhibition of HDAC activity prevented
masculinization of cell number in the BNSTp. Importantly, these
effects were dependent on hormone status, as HDAC inhibition
had no effect in females not treated with testosterone. Valproic
acid also had no effect on volume and cell number in two control
brain regions that were not sexually dimorphic. These findings
are consistent with the hypothesis that testosterone acts via
epigenetic processes, in particular the regulation of histone acetylation, to direct sexual differentiation of the brain that is determined by sex differences in cell death. In normal cell populations
treatment with an HDAC inhibitor alters the expression of a
relatively small number of genes. The genes affected, however, are
often related to the cell cycle or apoptosis (Glaser et al., 2003;
Menegola et al., 2007). The sex difference in cell number in the
BNSTp requires bax, a prodeath member of the bcl-2 family of
apoptosis related genes (Forger et al., 2004; Gotsiridze et al.,
2007).Therefore, a disruption of the hormonal regulation of bax
or other bcl-2 family genes is a potential mechanism of valproic
acid action.
Although an HDAC inhibitor blocked masculinization in the
BNSTp, it is unlikely that a simple formula such as “more acetylation equals more masculinization” will apply to all brain areas.
For example, males of many species have greater expression of the
neuropeptide vasopressin in the lateral septum than do females
(De Vries and Panzica, 2006). Preliminary findings suggest that
the same valproic acid treatment that blocks masculinization of
the BNSTp may masculinize vasopressin expression in female
mice (Murray et al., 2009b). Upon reflection, this is not surprising. It is unlikely that development of a masculine phenotype
depends on global increases in histone acetylation or that female
development requires uniformly less acetylation. Rather, gonadal
steroid hormones and their receptors, in conjunction with coactivators and corepressors with HAT or HDAC activity, respectively,
likely orchestrate orderly patterns of acetylation of histones associated with specific genes. This would lead to increased expression of
some genes in males and others in females, as is in fact what is seen
(Speert et al., 2007).
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Understanding the epigenetic regulation of cell number in the
BNSTp and in other brain regions may have important clinical
implications. The BNSTp plays a vital role in modulating emotional and stress responses (Choi et al., 2007, 2008) and sex differences in stress responsivity are well established (Bale, 2006).
Alterations in histone proteins and DNA methylation have been
identified in patients with schizophrenia, bipolar disorder, and
other psychiatric diseases, and several of the changes seen in patient populations are sex specific (Connor and Akbarian, 2008;
Akbarian and Huang, 2009). Thus, understanding how gonadal
steroids alter the neuronal epigenome is likely to be important for
explaining sex differences in the susceptibility to psychiatric and
neurological disease.
Sex differences in brain and epigenetic changes to
the germline
The discussion thus far has focused on epigenetic changes that
would be considered context dependent, meaning they occur
only within a single lifespan and may be transient within that
lifespan. This is indeed appropriate for changes that are opportunistically established in response to experience or hormone
exposure. Emerging evidence now indicates germline epigenetic
changes can also influence brain and behavior sex differences.
Environmental endocrine-disrupting compounds which either mimic or disrupt steroid hormone signaling are an increasing source of concern for numerous reasons. This list has been
made even longer by the observations of Andrea Gore, David
Crews, and colleagues of transgenerational changes in brain and
behavior induced by agricultural chemicals such as vinclozolin, a
fungicide with antiandrogenic activity (Skinner et al., 2008). A
wide ranging analysis of the transcriptome indicated that the expression of 92 genes in the hippocampus and 276 genes in the
amygdala were transgenerationally altered in males exposed to
vinclozolin. In the females, the expression of 1301 genes in the
hippocampus and 172 genes in the amygdala were transgenerationally altered. Examination of the F3 generation indicated opposite effects on anxiety-like behaviors in males versus females.
Relating transgenerational changes in the transcriptome to these
behavioral effects, and why and where they are different in males
and females presents a difficult but critical hurdle.
Along with the alarming increases in environmental chemicals of unknown action, industrialized nations have also witnessed rapid and profound elevations in obesity rates and, to a
lesser extent, height over the extraordinarily brief evolutionary
time scale of approximately five generations (James, 2008). While
stochastic Mendelian inheritance is not likely to explain such
rapid escalations, changes in available nutrition can clearly shape
these traits. However, putative epigenetic mechanisms by which
nutritive factors program future generations to inherit either an
obese or tall phenotype have not been well characterized. In response to maternal high fat diet during gestation and nursing,
Tracy Bale and Greg Dunn previously reported that two generations of offspring exhibit increased body length, reduced insulin
sensitivity, and reduced leptin levels. Both male and female firstgeneration offspring exposed to maternal high fat diet transmit
this phenotype to second-generation animals. That the paternal
lineage transmits the body length and insulin insensitivity traits is
compelling evidence of a germline-based epigenetic mechanism
of inheritance. This result avoids confounding variables associated with maternal transmission where potentially altered uterine
environment, maternal behavior, or metabolism and not an intergenerational epigenetic effect could influence the first- to
second-generation transmission. Additionally, their studies pro-
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vide evidence for a sex-dependent mechanism in both first- and
second-generation female offspring where female insulin-like
growth factor 1 (IGF-1) levels were masculinized by maternal
high-fat diet. Female-specific elevations in IGF-1 are accompanied by increased expression of the growth hormone-secretion
stimulating ghrelin receptor (GHSR). These alterations correlated
with significantly decreased expression of a GHSR-associated transcriptional repressor, AF5q31, exclusively in female offspring.
Transcriptional alterations in GHSR are associated with reduced
DNA methylation at the GHSR CpG island, providing a candidate epigenetic basis for the transmission of the phenotype.
Though Bale and Dunn are the first to report increased body
length in response to maternal diet, studies in a variety of model
organisms have detected the perpetuation of obesity, metabolic
syndrome, liver dysfunction, and cardiovascular disease through
at least the first generation (Férézou-Viala et al., 2007; Gniuli et
al., 2008; Parente et al., 2008). Exposure to altered maternal diet
and its physiological consequences can program offspring for
disease risk via a variety of mechanisms including leptin or insulin dysregulation, intrauterine growth restriction (IUGR), an altered supply of methyl donor molecules such as folic acid, or
gestational diabetes. However, acute exposure to altered maternal diet may result in some traits that terminate with the first
generation, whereas others may be epigenetically inherited by the
second generation. Moreover, sex differences exist in both the
capacity to transmit traits as well as to inherit them. For example,
recent evidence supports sex dependency in the transmission of
obesity and glucose intolerance resulting from maternal caloric
restriction, as reduced birth weight persisted in both male and
female second-generation offspring solely through the paternal
lineage whereas obesity transmitted only through the maternal
line in ICR strain mice (Jimenez-Chillaron et al., 2009). Embryo
transfer from pregnant IUGR rats to control rats resulted in hyperglycemia, hyperinsulinemia, and increased hepatic weight in
second-generation offspring, but only in females (Thamotharan
et al., 2007). However, repeatedly fasting adult male Swiss mice
resulted in the transmission of a reduced serum glucose phenotype to both male and female offspring, suggesting a germlinebased effect that is distinct from the phenotypes transmitted by
calorie restricted females (Anderson et al., 2006).
Additional research aims to parse out sex differences in heritability for maternal diet exposure phenotypes. A recent study in
rats detected increased body mass in second-generation males
but impairments in glucose metabolism in both sexes in response
to in utero protein restriction, supporting an inheritance dichotomy (Pinheiro et al., 2008). Furthermore, the timing of protein
restriction during development mediates sex-dependent inheritance in second-generation offspring, as male rats developed insulin resistance in response to restriction during the nursing
period while females developed sensitivity following gestational
restriction (Zambrano et al., 2005). In humans, examination of
the relationship between food supply and disease mortality across
generations in the Swedish parish of Overkalix revealed similar
sex differences in transmission and inheritance (Pembrey et al.,
2006). Links between grandmaternal diet during pregnancy and
granddaughters’ mortality risk were found in addition to associations between grandpaternal diet during the slow growth period
before puberty and mortality risk only in grandsons (Pembrey et
al., 2006). Excessive caloric intake in males during the slow
growth period also resulted in an increased risk for diabetesassociated mortality in grandchildren (Kaati et al., 2002). The
authors suggest that the sex specificity of transmission observed

McCarthy et al. • The Epigenetics of Sex Differences in the Brain

in these studies is due to the respective windows of sensitivity for
developing germ cells in males and females.
Exposure to both excessive and restricted consumption by
either parent results in sex-specific outcomes that vary in transmissibility. The findings of Bale and Dunn provide compelling
support for an adaptive, sex-dependent epigenetic mechanism
linking body size with maternal diet. As enhanced body size can
augment the fitness of an organism under certain circumstances,
an increase in body length in response to maternal high fat diet
provides an epigenetic contribution that may explain increases in
human height over the last century. These results are a novel but
not surprising addition to the body of evidence identifying the
consequences of maternal diet on the sex-specific inheritance and
transmission of traits. Genome-wide transcriptional variance
underwrites sexual dimorphisms observed between males and
females as a result of differential gonadal steroids, sex chromosomes, and imprinting.
Summary and conclusions
The relative importance of epigenetic modifications to the establishment and maintenance of sex differences in brain and behavior remains an open question, but that there is some role cannot
be denied. The promoter of the ER␣ gene appears to be a particularly robustly and reliably regulated site of epigenetic modification, but whether this is due to looking where the light is good, or
a genuine reflection of the essential biology, remains to be seen.
Histones and their acetylation are another source of sex-specific
responses and the observation that this includes effects on cell
death speaks to its fundamental importance. Expanding our field
of view beyond the classic brain regions involved in sexual differentiation of sex behavior reveals a rich array of additional effects
that include the response to brain injury, effects of endocrinedisrupting compounds, and the consequences of maternal diet to
the primary offspring and subsequent generations.
Together, these results suggest that despite the supremacy of
gonadal steroid hormones, the battle of the sexes is ultimately
fought upon the DNA. It is the combination of chromosomes,
steroid hormones, and early neonatal experiences that guide this
DNA scuffle. Ultimately we require a thorough understanding of
regulation of enzymes controlling acetylation and methylation,
coregulatory proteins, transient versus stable DNA methylation
patterns, steroid receptor cycling on/off DNA, and sex differences
across the epigenome to fully understand sex differences in brain
and behavior.
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